Notice of Change in Key Dates for PAR-18-009 "Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)"

Notice Number: NOT-CA-18-024

Key Dates
Release Date: November 30, 2017

Related Announcements
PAR-18-009

Issued by
National Cancer Institute (NCI)

Purpose

This Notice modifies the Key Dates Section of Funding Opportunity Announcement (FOA) PAR-18-009 "Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)".

Part 1. Key Dates

Currently reads:

Application Due Date(s): New Dates as per NOT-CA-17-034: The first due date for all types of applications allowed for this FOA is March 1, 2018. Thereafter, Standard dates apply, by 5:00 PM local time of applicant organization.  Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Modified to read (in italics):

Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Houston Baker, Ph.D.
National Cancer Institute (NCI) 
Telephone: 240-276-5908 
Email: [email protected]

Guo Feng Xu, Ph.D.
Center for Scientific Review (CSR)
Telephone: 301 827 4796
Email: [email protected]